Chau T. Dang - From the Departments of Pathology, Memorial Sloan Kettering Cancer Center

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 10 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Predictors of Response to CDK4/6i Retrial After Prior CDK4/6i Failure in ER+ Metastatic Breast Cancer

Nicholas Mai, Carlos H Dos Anjos,Pedram Razavi, Anton Safonov,Sujata Patil,Yuan Chen, Joshua Z Drago,Shanu Modi, Jacqueline F Bromberg,Chau T Dang,Dazhi Liu,Larry Norton,

Research square (2024)

引用0浏览0WOS引用

Abstract PO2-20-01: The STOP-HER2 Trial: A Phase 2 Study of Stopping Trastuzumab - Outcomes in Patients with HER2+ Metastatic Breast Cancer (TBCRC 062)

Heather Parsons,Kathryn Ruddy,Stefania Morganti,Karen Smith,Victoria Attaya, Eliza Kallfelz,Michelle DeMeo, Jamie LaScala, Shirley Mertz,Teri Pollastro,Patricia Spears,Adam Brufsky,

Cancer Researchno. 9_Supplement (2024): PO2-20

引用0浏览0引用

Abstract PO3-04-07: Characterization of response to first-line chemotherapy, trastuzumab, and pertuzumab among patients with de novo metastatic HER2-positive breast cancer

Emanuela Ferraro,Atif Khan,George Plitas, Yuan Chen, Mehnaj Ahmed, Julia An,Chau Dang, Mark Robson, Sarat Chandarlapaty, Shanu Modi, Pedram Razavi,Sherry Shen

Cancer Researchno. 9_Supplement (2024): PO3-04

引用0浏览0引用

Tips-10 feasibility of a multi-modality central nervous system screening evaluation in her2+ breastcancer patients

Rachna Malani,Andrew D. Seidman,Chau T. Dang,Katherine S. Panageas,Robert J. Young,Adrienne Boire,Jessica Wilcox

Neuro-oncology advancesno. Supplement_3 (2023): iii36-iii36

引用0浏览0引用

Abstract P4-02-14: Gain of HER2 Amplification in Patients with HR+/HER2- and Triple Negative Early Breast Cancer Treated with Neoadjuvant Chemotherapy

Emanuela Ferraro, Sonya Chew Minmin, Anton Safonov, Andrea V. Barrio, Shanu Modi, Andrew D Seidman,Hanna Y Wen, Edi Brogi, Mark E. Robson,Chau T Dang

Cancer Researchno. 5_Supplement (2023): P4-02

引用0浏览0引用

Sdps-46 central nervous system (cns)-related mortality in patients with her2-positive metastatic breast cancer

Emanuela Ferraro, Rabih Bou Nassif,Anne S. Reiner,Umberto Tosi,Katherine S. Panageas,Chau T. Dang,Andrew D. Seidman,Nelson S. Moss

Neuro-oncology advances（2023）

引用0浏览0引用

Abstract GS3-03: Genomic analysis of 733 HER2+ breast cancers identifies recurrent pathways alterations associated with anti-HER2 resistance and new therapeutic vulnerabilities

Emanuela Ferraro,Alison Smith,Anton Safonov,Paulino Tallon De Lara,Cristina Bernado',Enrique J. Arenas Lahuerta,Joaquín Arribas,David Solit,Jorge S. Reis-Filho,Neal Rosen,Larry Norton,Shanu Modi,

Cancer Researchno. 4_Supplement (2022): GS3-03

引用0浏览0引用

ASO Visual Abstract: Neoadjuvant Chemotherapy for Breast Cancer in the Elderly—Are We Accomplishing Our Treatment Goals

Austin D. Williams,Chau T. Dang,Varadan Sevilimedu,Monica Morrow,Andrea V. Barrio

Annals of Surgical Oncologyno. 13 (2022): 8014-8015

引用0浏览0引用

Incidence Of Brain Metastases In Patients Receiving Neoadjuvant Chemotherapy (Nac) With Trastuzumab And Pertuzumab (Hp) In Her2-Positive Early Breast Cancer (Bc)

Emanuela Ferraro,Andrea Veronica Barrio,Sujata Patil,Mark E. Robson,Chau T. Dang

JOURNAL OF CLINICAL ONCOLOGY（2020）

引用3浏览0引用

Impact of the 2018 American Society of Clinical Oncology/College of American Pathologists HER2 Guideline Updates on HER2 Assessment in Breast Cancer With Equivocal HER2 Immunohistochemistry Results With Focus on Cases With HER2/CEP17 Ratio <2.0 and Average HER2 Copy Number ≥4.0 and <6.0

Raza S. Hoda,Edi Brogi,Jin Xu,Katia Ventura,Dara S. Ross,Chau Dang,Mark Robson,Larry Norton,Monica Morrow,Hannah Y. Wen

Archives of Pathology & Laboratory Medicineno. 5 (2019): 597-601

引用0浏览0引用

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn